Home | Back to newsletter main page
 |
|
December 20, 2010 |
|
CASE CCC IN THE NEWSResearchers Work to Improve Cancer Vaccines Case Licenses Cell Lines to British Firm for Cancer Research Study: Aspirin May Help Combat Cancer Rare Genetic Syndrome May Increase Colon Cancer Risk FUNDING OPPORTUNITIESDamon Runyon Cancer Research Foundation Clinical Investigator AwardCWRU SOM has been invited to nominate up to three individuals for the Damon Runyon Cancer Research Foundation Clinical Investigator Award. This award supports young physician-scientists conducting patient-oriented cancer research, with a goal of increasing the number of physicians capable of moving seamlessly between the laboratory and the patient's bedside in search of breakthrough treatments. New this year is a novel partnership with the National Institutes of Health (NIH) and the National Cancer Institute (NCI), which opens access to the NIH Clinical Center (CC) to Damon Runyon Clinical Investigators. The goal of this partnership is to use the special talent, expertise and resources of the participants to undertake pilot studies of specific diseases and to develop collaborative partnerships that accelerate clinical and translational cancer research, and thereby improve human health. See the website for more information. If you are interested in applying for this award, please submit the following materials to cancer@case.edu by Monday, January 10: biosketch and a one-paragraph description of how your research fits the description of "Clinical Research" as described by the Damon Runyon Foundation. Internal Deadline: January 10 Mary Kay Foundation Cancer Research Grant ProgramThe Mary Kay Foundation has released a Call for Applications for their Cancer Research Grant Program. This non-profit public foundation focuses on funding research for innovative grants for translational research in ovarian, uterine, breast or cervical cancer. Translational research is broadly defined as research that will provide a scientific link between laboratory research and the clinic. Ultimately, such research would lead to improvement in diagnosis, prognosis, prevention, or treatment of the cancer. Only ONE application per institution is allowed. Investigators interested in applying must submit their biosketch and a one-paragraph description to cancer@case.edu by Wednesday, January 5. Internal Deadline: January 5 |
EVENTS
**All events are open to anyone interested in attending December 20Physiology and Biophysics Seminar December 21December 22Hematology and Oncology Division Research Conference canceled December 23December 24Merry Christmas!
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTSCancer Center Seminar Series ADDITIONAL UPCOMING SEMINARS & EVENTSActive Living Research Annual Conference Multilevel Interventions in Health Care: Building the Foundation for Future Research Goals 4th Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen Science 2011 Clinical and Translational Research and Education Meeting: ACRT/SCTS Joint Annual Meeting Cancer Health Disparities Summit 2011 |
LUNGevity FoundationLUNGevity provides funding for the study of early detection of lung cancer and targeted therapeutic treatments for lung cancer. LUNGevity invites grant applications for the following opportunities: Lung Cancer Targeted Therapeutics Program and Lung Cancer Early Detection Award (LCED) Program. Applications will be accepted from individual investigators or teams of up to three scientists. Grants will be awarded for a two-year period for a maximum amount of $100,000 per year per scientist. Mandatory LOI Deadline: December 22 Avon Foundation Breast Cancer Research ProgramThe Avon Foundation for Women continues to seek new preventive strategies to address the growing number of breast cancer cases around the globe. To develop new strategies to prevent breast cancer we need to understand the causes of breast cancer in women, changes in breast cells that give rise to cancer, markers for disease, and how breast cancer progresses. The 2011 Avon Foundation Research Program seeks proposals in these areas to advance understanding of causes of breast cancer and prevention. For 2011, there are two receipt dates (review cycles) and there is a 2-stage process:
Lasker Medical Research AwardsThe Lasker Foundation is accepting nominations for the 2011 Lasker Medical Research Awards. The Medical Research Awards will be offered in two categories in 2011: Basic Medical Research and Clinical Medical Research. The Awards are intended to recognize contributions that have opened new fields of research, advancing novel concepts or their applications in a particular biomedical discipline. These advances may consist of a specific contribution or a long series of contributions that demonstrate the nominee's significant leadership towards the development of research concepts or their clinical application. Nomination Deadline: February 1, 2011 |
NCI Cancer BulletinDecember 14, 2010News Commentary In Depth Updates |
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES |
|
|
Landon Foundation-AACR INNOVATOR Award for International Collaboration |
2011 Jane Coffin Childs Memorial Fund for Medical Research Fellowship Awards |
NIH BULLETIN – Notices and Funding OpportunitiesCancer Prevention Research Small Grant Program (R03) (PAR-11-079) |
|
| Produced by: Gillian Irwin Todd 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216-844-8317 phone 216-844-7832 fax gillian.irwin@case.edu |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
|
|